TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
WGS

GeneDx Holdings Corp.

Healthcare · Diagnostics & Research

90.80$ -7.2% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet WGS
Line item 2019 2020 2021 2022 2023 2024 2025
+120.2% -1.6% -23.2% +0.1% +36.0%
+6.3% +177.7% -56.0% -14.2% +8.6% +35.5%
+270.4% -65.7% -27.5% -14.5% +23.2%
+270.4% -65.7% -5.3% +8.5% +21.3%
+49.4% -17.8% +63.2% -24.3% +14.7% +97.6%
+56.2% +34.0% -59.2% -35.8% +21.3% +31.0%
+79.0% -0.6% +34.4%
-7.5% -8.1% +6.2%
-32.9% +75.6% -34.6% -8.7% +50.5%
+82.8% +37.9% +42.5% -59.2% -6.8% +98.7%
-2.5% +218.0% -61.9% -19.5% +168.2%
+53.0% +67.2% +3.0% -77.8% -22.3% -69.1%
-42.0% -43.2% +743.0% -1.5% -7.2%
+8,744.6% -34.6% -10.1% +7.6% +25.7%
+0.0% -41.8% +212.6% +137.5% +10.6% +0.0%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?